Meet StaClear at Medica: Nov 17-20, 2025, Düsseldorf, Germany
StaClear to Exhibit at MEDICA 2025, The First Low-Particulate Ophthalmic Syringe With CE Marking
Düsseldorf, Germany | November 17–20, 2025, Hall 16 / F11-1 | USA Pavilion – North Carolina Section
StaClear, manufacturer of the low-particulate ophthalmic syringe that recently received its CE marking, will exhibit at MEDICA 2025, the world’s leading medical trade fair.
Why StaClear Is Coming to MEDICA
StaClear Low-Particulate Ophthalmic Syringe Receives CE Mark Under New EU MDR Requirements
RALEIGH, North Carolina, [July 15, 2025] – StaClear, Inc. today announced that its low-particulate ophthalmic syringes have received CE marking under the updated European Medical Device Regulation (EU MDR), affirming compliance with the latest EU safety, quality, and performance standards.
One Compounding Pharmacy’s Experience With StaClear Syringes
“Our syringe rejection rate went down dramatically with the StaClear syringes. This saves us money, time, and headaches from a Quality perspective."
An interview with Mike Basista, Supervising Pharmacist at RC Outsourcing, LLC a leading 503B outsourcing facility in the United States serving retina specialists
